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Abstract 
Introduction: The burden of raised blood pressure and elevated blood glucose in sub-Saharan Africa has been 
increasing over the last couple of decades. However, a large proportion of the population with raised blood 
pressure and elevated blood glucose remain undiagnosed contributing to the increasing burden of the problem.  
There is paucity of published studies describing the burden of major NCDs in sub –Saharan Africa. Likewise, 
except very few studies in some pocket areas, there was no representative NCD risk factor survey undertaken in 
Ethiopia.  This paper focuses on the data extracted from the survey on the prevalence of selected NCDs to 
elaborate more on the issues and to show the invisible magnitude of the two major health problems for policy and 
program development.  
Methods:  A cross sectional study was conducted in Ethiopia using the WHO step-wise approach to the 
surveillance of NCD risk factors. The survey was carried out between April and June 2015. The data collection 
processes included three steps.  Step 1: This step comprised of a questionnaire to gather demographic and 
behavioural characteristics of the study population; Step 2: Physical measurement was done to build on the core 
data in Step 1 and to determine proportion of the study population with raised blood pressure, overweight and 
obesity; and Step 3: Biochemical measurements were undertaken to build on the core data in step 1 and step 2 to 
measure proportion of the study population with diabetes, raised blood glucose and abnormal lipid level. Data 
were collected digitally using personal digital assistants (PDAs) from which data were transferred to central server 
using internet file streaming system (IFSS). Data were cleaned and analysed using a combination of softwares 
namely, SPSS, Stata and Epi Info version 3.5.4.  
Results: The survey included 9,788 study participants and of this, 77%   had never been measured for blood 
pressure prior to current survey. However, based on the measurements made during the present survey among all  
respondents who were not taking medication for raised blood pressure, 15.6% (95% CI: 14.4-16.9) had raised 
blood pressure level ( SBP of ≥140 mmHg and/or a DBP of ≥90 mmHg). Likewise, among all respondents, 97 % 
had never been tested for blood sugar level prior to present survey. However, the current study revealed a total of 
5.7 % of the study population had a blood glucose level of ≥ 110 mg/dl, with 6% (95% CI: 4.7-7.2) in men, and 
5.8 %( 95% CI: 4.6-7.0) in women. 
Conclusions: The prevalence of undiagnosed raised blood pressure and elevated blood sugar was high in Ethiopia 
and only very small percentage of people had been aware of their high blood pressure and elevated blood sugar. 
Policy makers in the health sector including other health development partners need to strengthen health system 
and design nation-wide population based strategy to establish community based screening program for blood 
pressure and blood glucose.  [Ethiop. J. Health Dev.  2017;31(Special Issue):362-369]  
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Background 
In countries across the world, regardless of geographic 
location, size of population or stages of social and 
economic development, non-communicable diseases 
(NCDs) are responsible for high proportion of death 
and disability. As the leading cause of death globally, 
NCDs particularly cardiovascular diseases (CVDs), 
diabetes, chronic respiratory diseases and cancer were 
responsible for 38 million (68%) of the World's 56 
million deaths in 2012. Almost three quarters of all 
NCD deaths (28 million), and the majority of 
premature deaths (82%) occur in low-and middle-
income countries(1).In many low–income countries it 
is estimated  to exceed as the most common causes of 
death by 2030 (2). Diabetes mellitus and hypertension 
are among the commonest non-communicable diseases 
in both developed and developing countries(3).The 
burden of raised blood pressure and elevated blood 
glucose in sub-Saharan Africa have been increasing 
over the last couple of decades. However, a large 
proportion of the population with raised blood pressure 
and elevated blood glucose remain undiagnosed, 
contributing to the increasing burden of the problem. 
Epidemiologic studies indicate that non-communicable 
diseases are emerging as a major disease burden in 
Africa and hence continue to be a challenge with a 
double burden of disease from pre-existing 
communicable diseases and the emerging NCD 
epidemic (8, 9). Hypertension, also known as high or 
raised blood pressure, is a global public health issue. It 
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contributes to the burden of heart disease, stroke and 
kidney failure and premature mortality and disability. It 
disproportionately affects populations in low- and 
middle-income countries where health systems are 
weak. WHO estimates that globally cardiovascular 
disease accounts for approximately 17 million deaths a 
year, nearly one third of the total (13) .Of these, 
complications of hypertension account for 9.4   million 
deaths worldwide every year (4). Hypertension is 
responsible for at least 45% of deaths due to heart 
disease  and 51% of deaths due to stroke (13).There are 
significant health and economic gains attached to early 
detection, adequate treatment and good control of 
hypertension. Treating the complications of 
hypertension entails costly interventions such as 
cardiac bypass surgery, carotid artery surgery and 
dialysis which drains individual and government 
budget. Addressing behavioural risk factors, e.g. 
unhealthy diet, harmful use of alcohol and physical 
inactivity, can prevent hypertension. Tobacco use 
increases the risk of complications of hypertension. If 
no action is taken to reduce exposure to these factors, 
cardiovascular disease incidence, including 
hypertension, will increase. Prevention and control of 
hypertension is complex, and demands multi-
stakeholder collaboration, including governments, civil 
society, academia and the food and beverage industry. 
In view of the enormous public health benefits of blood 
pressure control, now is the time for concerted action 
(13). 
 
Hyperglycaemia, or elevated blood sugar, is a common 
effect of uncontrolled diabetes and over time leads to 
serious damage to many of the body's systems, 
especially the nerves and blood vessels (14). While 
blood glucose level is an important prognostic 
parameter, it is the central or most important feature 
determining prognosis in people with hyperglycaemia 
in terms of screening asymptomatic people, to decrease 
the burden and gain medical, social and economic 
benefits accordingly. Early diagnosis and treatment of 
diabetes is the major determinant in preventing 
premature mortality as well as delaying or preventing 
long term diabetic complications leading to a more 
healthy life. The longer a person lives with 
undiagnosed and untreated diabetes, the worse their 
health conditions are likely to be. Easily accessible 
basic diagnostics, such as blood pressure and glucose 
testing/measurement, and referral system should 
therefore be available in primary health-care settings 
(15). For those who are diagnosed with diabetes, a 
series of cost-effective interventions can improve their 
outcomes, regardless of what type of diabetes they may 
have. These interventions include blood glucose 
control, through a combination of diet, physical activity 
and, if necessary, medication; control of blood pressure 
and lipids to reduce cardiovascular risk and other 
complications, and regular screening for chronic 
complications such as damage to the eyes, kidneys and 
feet, in order to facilitate early detection and treatment 
(15). 
 
Except very few studies in some pocket areas and 
national estimations like GBD, there is no national 
representative quantitative information on the burden 
of chronic diseases or their risk factors in Ethiopia.  
Furthermore, the existing health management 
information system (HMIS) fails to capture complete 
information. In one of the administrative zones of 
Ethiopia, a population-based cross-sectional STEPS 
survey was conducted in 2009 at Gilgel Gibe, one of 
the Ethiopian demographic and surveillance sites. In 
this study, a random sample of 4,469 individuals’ age 
15-64 years were studied and overall prevalence of 
NCDs was 8.9%. Prevalence of 3.1% for diabetes, 
9.3% for hypertension, 3.0% for cardiovascular 
diseases  (11). Despite the limitations in the health 
management information system (HMIS) of Ethiopia, 
non-communicable diseases such as hypertension and 
diabetes mellitus appear on the list of leading causes of 
morbidity and mortality in the hospitals and regional 
health bureaus across the country(12). In response to 
the above challenges, several efforts were exerted  by 
the Ethiopian government to tackle the problem of 
NCDs. FMOH is responding with measures that lessen 
the risk factors that are associated with NCDs. In 
accordance with the 2011 UN political declaration on 
NCDs, the FMOH has developed and launched the 
National NCD Prevention and Control Strategic Plan. 
The government of the Federal Democratic Republic of 
Ethiopia has endorsed the WHO Framework 
Convention on Tobacco Control, following which the 
Food, Medicine and Health care Administration and 
Control Authority developed directives for 
implementation of the convention. Data on prevalence 
of NCD risk factor will inform policy makers to design 
evidence-based public health interventions to prevent 
and control the epidemics of NCDs. In the present 
study the investigators have used data extracted from 
NCD STEPS survey to produce this particular article. 
The main purpose of this investigation is to disclose the 
invisible magnitude of raised blood pressure and 
elevated blood glucose in Ethiopia.  Existing evidences 
inform us that the epidemic can be reduced by 
preventing and controlling the four behavioural risk 
factors for NCDs: tobacco use, insufficient physical 
activity, harmful use of alcohol, and consumption of 
unhealthy diet. According to EDHS 2011, some of 
behavioural risk factors (tobacco use, alcohol 
consumption, and khat chewing) were considered (10). 
 
Methods   
Study setting:  The survey was conducted in the 9 
regions and two city administrations (Addis Ababa and 
Dire Dawa) in Ethiopia. Each region is divided into 
administrative zones and the two city administrations 
are divided into sub-cities. The administrative zones in 
the nine regions and sub-cities in the two city 
administrations are subdivided into districts or 
(Woreda). The districts (Woredas) are also further 
divided into Kebele. The Kebeles are the smallest 
administrative units with clear geographic delineation 
in Ethiopia. Within Kebeles, there are Enumeration 
Areas (EAs) which are delineated by the Central 
Statistical Agency (CSA) of Ethiopia. According to the 
2007 population and housing census, there were a total 
of 15,837 Kebeles in Ethiopia i.e. 14,364 rural and 
1,473 urban kebeles. A single population-proportion 
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formula was used to determine the sample size. To 
adjust for the design effect, a complex sampling design 
effect coefficient of 1.5 was used to compute the 
sample size. In the present study, a mix of sampling 
approach: stratified, three-stage cluster sampling, 
simple random sampling and Kish method were 
employed to select the study areas and the study 
participants. Twenty households were selected from 
each EA using systematic sampling. Eligible 
individuals were selected from each household using 
Kish method. A total of 10,260 study participants were 
sampled to be included in the study. The study was 
actually conducted in 513 selected enumeration areas 
from mid-April to end-June 2015. 
 
Study population:  The target population for this 
survey included all men and women age 15-69 years 
old who consider Ethiopia to be their primary place of 
residence who are living at their place of residence for 
at least six months.  This definition included those 
individuals residing in Ethiopia regardless of their 
citizenship status.  Individuals who were not a 
permanent resident of Ethiopia, those who were 
institutionalized-including people residing in hospitals, 
prisons, nursing homes, and other similar institutions or 
residents whose primary residences are military camps 
or dormitories, critically ill, and mentally disabled were 
excluded from this study. 
 
Data collection procedures:  The data collection 
processes included three steps. Step 1:This step 
comprised of a questionnaire to gather demographic 
and behavioural characteristics of the study population; 
Step 2: Physical measurements were done to build on 
the core data of step 1 and to determine proportion of 
the study population with raised blood pressure, 
overweight and obesity; and Step 3: Biochemical 
measurements were undertaken to build on the core 
data in step 1 and step 2 to measure proportion of the 
study population with diabetes, raised blood glucose 
and abnormal lipid level. 
 
Blood pressure and heart rate measurements were taken 
three times on the right arm of the survey participants 
in a sitting position, using a Boso-Medicus Uno 
instrument (Boso is the Bosch + Sohn GmbH & Co. 
KG, Germany) with a universal cuff and automatic 
blood pressure and heart rate monitor. The mean of 
three measurements was taken for analysis. The 
measurements were taken after the participant had 
rested for 15 minutes, and each measurement was done 
with three minutes interval (maximum deviation of cuff 
pressure measurement ± 3 mmHg, and of pulse rate 
display ± 5%). Regarding blood test, Cardio Check PA 
analyser (manufactured by BHR Pharmaceuticals Ltd) 
was used to test fasting blood glucose, and the next day 
after STEPS 1 and 2 of the data collection, 
concentrations of glucose were measured in capillary 
blood on a fasting blood sample. 
 
Data analysis:  Descriptive weighted analysis was 
done along with bivariate and multivariate analysis. 
Further statistical analyses were done by using chi- 
squared tests and logistic regression models. Chi- 
squared tests were used when comparing groups. All 
factors with a p-value <0.05 in the bivariate analysis 
were further entered into the multivariate model to 
control for confounding effects. Odds ratios (OR) with 
95% confidence intervals (CI) were calculated. 
Statistical significance was accepted at the 5% level 
(p<0.05). To identify the association of raised blood 
pressure and elevated blood glucose with socio 
demographic characteristics, bivariate and multivariate 
logistic regression analysis was conducted. After 
performing bivariate analysis, based on the significance 
levels and categories of risk factors (modifiable and 
non-modifiable risk factors) of each independent 
variable multivariate analysis was conducted. 
 
Ethical considerations:  Ethical clearance was 
obtained first from the EPHI Institutional review board 
(IRB) then from national research and ethics review 
committee. Data were collected unlinked anonymously, 
without any personal identifiers. For the purpose of 
data collection, informed consent was obtained from 
the study participants before administering the 
questions/collecting blood sample, and objective of the 
study was explained to the study participants. For 
participants under 18 years of age, assent and consent 
from their parents or guardians was obtained. 
Individuals with abnormal physical and biochemical 
results were referred to the near-by health facilities for 
further investigation, diagnosis and follow up.  
 
Results  
Characteristics of survey participants:  Table 1 shows 
a total of 9,800 respondents, age 15-69 years were 
involved in the survey and the response rate was 
95.5%. Of the total 9,800 respondents of STEPS 
survey, about six in ten were women.  Nearly three 
fourth 7,113 (73%) of the respondents were from rural 
area. High proportion of the respondents (40%) were 
within the age group of 15 – 29 followed by age group 
of 30-44 years. 
 
Experience of blood pressure measurement and 
magnitude of hidden raised blood pressure:  Table 2 
shows 77% of study participants had never been 
measured for blood pressure prior to the current survey. 
The results of those who had never been measured 
ranged from 40.2 % in Addis Ababa to 91.7 % in 
Harari. The present study has also collected 
information on raised BP by history and revealed that 
0.5% of the respondents were diagnosed to have raised 
BP prior to this survey and were under medication 
whereas 15.6 % were unaware of their raised blood 
pressure level. However, based on the measurements 
made during the present survey among all the 
respondents, 15.6% were found to have raised blood 
pressure with a SBP of ≥140 mmHg and/or a DBP of 
≥90 mmHg. The result also showed increasing trend of 
elevated blood pressure with age advancement among 
those who were unaware of their raised blood pressure. 
The proportion of men in this category was 15.3% and 
that of women was 16.0%. 
 
There were administrative regions with low and high 
prevalence of blood pressure in reference to national 
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average. Among the regions, the highest prevalence 
was seen in Gambella 24.6% followed by Addis Ababa 
22.6%. Likewise, administrative regions with low 




Table 1: Survey respondent distribution by age, sex, area of residence and administrative  


























Table 2: Proportion of respondents who were unaware of  their raised blood pressure,  history of blood pressure 
measurement and treatment among those previously diagnosed with raised blood pressure by age, sex, area of 
residence  and administrative region, Ethiopia NCD STEPS, 2015 
Variables 
Never measured for  blood 
pressure among total 
respondents (N=9,788) 
Treatment for raised blood 
pressure by history 
(N=9,671) 
Respondents who were 
unaware of their raised 
blood pressure status 
(N=9,599) 
Age group n % 95% CI n % 95% CI n % 95% CI 
  15-29 3230 81.7 79.8-83.6 12 0.3 0.1-0.5 413 10.6 8.9-12.2 
   30-44 2556 73.1 70.7-75.5 14 0.4 0.1-0.7 645 18.80 16.7-20.8 
   45-59 1128 66.9 63.2-70.6 13 0.8 0.4-1.2 387 23.7 21.0-26.4 
   60-69 413 63.4 57.5-69.3 12 1.8 0.0-4.1 238 37.6 31.8-43.5 
Sex 0     0     0     
   Male 3240 81.6 79.6-83.6 16 0.4 0.2-0.7 596 15.3 13.5-17.1 
   Female 4113 70.7 68.4-73.0 29 0.5 0.3-0.7 913 16 14.6-17.5 
Area of residence   0     0     0     
   Urban 1704 63.5 57.3-69.7 32 1.2 0.6-1.8 492 19 16.4-21.7 
   Rural 5662 79.7 77.9-81.6 21 0.3 0.1-0.5 1044 14.9 13.4-16.3 
Region 0     0     0     
   Addis Ababa 327 40.2 35.1-45.3 14 1.7 0.7-2.7 179 22.6 18.1-27.0 
   Afar 348 90.5 82.8-98.2 2 0.4 0.0-1.1 30 8 4.0-11.9 
   Amhara 1486 79.7 75.8-83.7 7 0.4 0.1-0.8 265 14.5 12.0-17.0 
   B.Gumuz 297 77.6 70.6-84.6 0 0 0.0-0.0 68 18 6.9-29.1 
   Diredawa 214 83.3 77.3-89.3 2 0.8 0.0-1.6 35 14.1 8.9-19.4 
   Gambella 250 85.4 75.9-95.0 0 0 0.0-0.0 72 24.6 12.3-36.8 
   Harari 196 91.7 85.8-97.6 4 2.1 0.5-3.7 42 20 12.5-27.6 
   Oromia 1700 73.7 70.6-76.8 16 0.7 0.3-1.0 309 13.6 11.8-15.4 
   SNNPR 1388 81.4 77.8-85.1 2 0.1 0.0-0.2 367 22 18.6-25.4 
   Somali 488 79.6 71.8-87.4 6 0.9 0.1-1.7 72 11.9 8.2-15.6 
   Tigray 702 73.6 69.3-77.9 0 0 0.0-0.0 83 8.9 6.7-11.0 






Male Female Total 
n % n % n % 
Age Group       
   15 - 29 1441 36.4% 2518 63.6% 3959 40.4 
   30 - 44 1438 41.1% 2061 58.9% 3499 35.7 
   45 - 59 781 46.2% 909 53.8% 1690 17.2 
   60 - 69 317 48.6% 335 51.4% 652 6.7 
Total 3977 40.6% 5823 59.4% 9800 100 
Place of residence       
   Urban 777 28.9% 1910 71.1% 2687 27.4 
   Rural 3200 45.0% 3913 55.0% 7113 72.6 
Total 3977 40.6% 5823 59.4% 9800 100 
Administrative region       
   Tigray 360 37.7% 595 62.3% 955 9.7 
   Afar 176 45.8% 208 54.2% 384 3.9 
   Amhara 827 44.3% 1040 55.7% 1867 19.1 
   Oromiya 995 43.1% 1313 56.9% 2308 23.6 
   Somali 215 35.0% 400 65.0% 615 6.3 
   Benishangul Gumuz 185 48.2% 199 51.8% 384 3.9 
   SNNPR 730 42.8% 976 57.2% 1706 17.4 
   Gambela 147 49.8% 148 50.2% 295 3.0 
   Harari 88 41.1% 126 58.9% 214 2.2 
   Dire Dawa 96 37.4% 161 62.6% 257 2.6 
   Addis Ababa 158 19.4% 657 80.6% 815 8.3 
Total 3977 40.6% 5823 59.4% 9800 100 
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Experience of blood glucose measurement and 
hidden magnitude of elevated blood glucose:  As can 
be seen from Table 3, among those never tested (97%) 
for blood glucose the lowest was in Addis Ababa and 
the highest was in Gambella 80.3% and 99%, 
respectively. 
 
Table 3: Proportion of respondents who were unaware of their elevated blood sugar,  history of blood 
glucose test and treatment  among those previously diagnosed with elevated blood sugar by age, sex,  area 
of residence  and administrative region, Ethiopia NCD STEPS, 2015 
Variables Never measured for blood 
sugar among total 
respondents (N=9,790) 
Treatment for elevated 
blood sugar by history 
(n=8,511) 
Respondents who were 
unaware of their elevated 
blood sugar status 
(N=8,435) 
Age group n % 95% CI n % 95% CI n % 95% CI 
   15-29 3888 98.3 97.8-98.8 7 0.2 0.0-0.4 161 4.9 3.6-6.3 
   30-44 3370 96.4 95.5-97.2 12 0.4 0.1-0.6 179 5.9 4.5-7.2 
   45-59 1586 94 92.5-95.6 21 1.4 0.6-2.2 105 6.9 5.2-8.6 
   60-69 603 92.5 89.9-95.2 10 1.6 0.7-2.5 64 10.8 7.2-14.3 
Sex          
   Male  3868 97.4 96.7-98.1 16 0.4 0.2-0.7 209 5.9 4.6-7.1 
   Female  5610 96.4 95.8-97.1 33 0.6 0.3-0.8 269 5.5 4.3-6.7 
Area of 
residence   
          
Urban 2430 90.5 88.3-92.6 31 1.4 0.8-2.1 149 6.7 4.2-9.1 
Rural 6998 98.5 98.1-98.9 19 0.3 0.1-0.5 341 5.5 4.4-6.6 
Addis Ababa 652 80.3 76.9-83.7 17 2.5 1.0-4.1 29 4.4 2.6-6.1 
Afar 385 98.2 95.2-100.0 1 0 0.0-0.0 30 10 2.2-17.8 
Amhara 1819 97.9 97.1-98.8 5 0.3 0.1-0.6 29 1.8 0.6-2.9 
B.Gumuz 377 98.3 95.9-100.0 2 0.4 0.0-1.0 30 9.4 0.0-22.8 
Diredawa 242 93.3 86.3-100.0 2 0.6 0.0-1.6 28 13.9 6.3-21.5 
Gambella 271 98.6 96.9-100.0 2 0.2 0.0-0.6 24 9 0.0-19.0 
Harari 205 97.4 96.0-98.8 2 1 0.0-2.5 31 18.1 0.5-35.8 
Oromia 2267 97.2 96.3-98.1 8 0.4 0.1-0.7 116 5.7 4.1-7.4 
SNNPR 1658 97.6 96.4-98.8 11 0.7 0.2-1.2 160 10.5 7.4-13.7 
Somali 559 91.1 86.5-95.7 5 0.9 0.0-1.9 115 22.8 15.7-30.0 
Tigray 925 96.9 95.2-98.6 3 0.4 0.0-0.8 18 2.1 1.0-3.3 
TOTAL 9496 97 96.4-97.5 43 0.5 0.3-0.7 481 5.7 4.7-6.7 
 
This study h as also collected information about 
elevated blood glucose by history and found 0.5% of 
the respondents were diagnosed to have diabetes and 
they were under medication. The results obtained by 
history ranged from 0% in Afar and 0.2% in Gambella 
to 1% in Harari and 2.5% in Addis Ababa. 
 
However, the current study revealed a total of 5.9 % of 
the study population had a blood glucose level of 
greater than or equal to 110 mg/dl, with 6% in men, 
and 5.8 % in women. The proportion of the study 
population with elevated blood glucose values was 
found to increase with advancement of age from 4.9% 
(age group 15–29 years) to 10.8% in those age group 
60–69 years. 
 
Among the administrative regions of the country, the 
hidden magnitude ranged from 1.8 % in Amhara and 




The findings disclosed the prevalence of undiagnosed 
raised blood pressure and elevated blood glucose. Our 
study adds to the limited body of evidence on raised 
blood pressure and elevated blood glucose in Ethiopia 
which will contribute to the efforts of Ministry of 
Health to develop and implement policies to reduce 
death and disability from non-communicable diseases. 
Prevention and control of raised blood pressure and 
elevated blood glucose are one of the cornerstones of 
these efforts. 
In this study, the findings mainly focused to describe 
the invisible prevalence of raised blood pressure and 
elevated blood glucose among adults in Ethiopia. It 
was found that 77 % and 97% of study participants had 
never been measured/tested for their blood pressure 
and blood glucose level prior to the present survey, 
respectively. This suggests that the greater proportion 
of individuals with raised blood pressure and/or blood 
sugar are unaware of their health condition which is 
consistent with other similar studies within Ethiopia 
(16).  Evidences suggest that our findings were much 
higher than other similar studies outside the country 
such as 39.2 % in Bangladesh (17), 42.6% Mongolia 
(18), 33.6% in Myanmar (19), 50% in Uganda, South 
Africa, Tanzania and Nigeria (20)  but lower than 
Botswana (21) and Malawi (22) where more than 8 and 
9 in ten never measured for raised blood pressure and 
elevated blood glucose, respectively. This indicates 
that despite variations in study area, study design, 
sample size and other underlying differences in study 
population characteristics (e.g. age distributions, 
gender, urban or rural residents etc), available evidence 
suggests that the health seeking behaviour of the 
community and screening for hypertension and 
diabetes at health facility  is found to be  poor in 
Ethiopia (16, 23). 
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Moreover, the practice to be screened for elevated 
blood sugar is more uncommon among Ethiopians 
which is comparable with other similar studies in 
different countries where more than 8 in ten 
participants in Myanmar (84.4%), Bangladesh (83.0%). 
Mongolia (85.2%). and Botswana (98.3%) were never 
tested for elevated blood glucose (17-19, 21). 
 
In this survey, 15.6 % of 9,788 study participants were 
found to have raised blood pressure. High number of 
study participants with raised blood pressure suggests 
that there is low awareness of these risk factors among 
the study population. Raised blood pressure is highly 
prevalent among the urban population and people aged 
45 years and above which is slightly higher than  the 
study at Gondar where one in every four adults(28.3%) 
aged 35 years or older had hypertension in Gondar city 
(23). A study conducted among civil servants in Addis 
Ababa also showed a higher prevalence for raised 
blood pressure where the overall prevalence of 
hypertension was 27.3 % (24), similarly a study 
conducted among general population of Addis Ababa 
also revealed  higher prevalence of raised blood 
pressure where 1 in 4 had raised blood pressure (25)  . 
The overall prevalence rate of hypertension in SSA for 
2008 was estimated at 16.2% (6), ranging from 10.6% 
in Ethiopia to 26.9% in Ghana(6). The estimated 
prevalence was 13.7% in rural areas, 20.7% in urban 
areas, 16.8% in males, and 15.7% in women (26).  The 
possible explanation for the differences in the findings 
could be due to the differences in the methodological 
approaches (study setting being urban and rural, study 
population, sample size etc…). 
 
Even though the type of diabetes was not yet specified, 
5.7% of 9,790 study participants were newly diagnosed 
and found to have elevated blood glucose level. Studies 
revelled that Type 2 diabetes accounts for well over 
90% of diabetes in sub-Saharan Africa, and population 
prevalence proportions ranged from 1% in rural 
Uganda to 12% in urban Kenya (27) whereas reported 
type 1 diabetes prevalence was low and ranged from 4 
per 100,000 in Mozambique to 12 per 100,000 in 
Zambia (27). This suggests that elevated blood sugar 
prevalence is increasing in developing countries, and 
Ethiopia is no exception in which diabetes exerts a 
significant burden and this is expected to increase if 
there is no mechanism to screen in its early stage at 
community level. Studies suggest that the awareness of 
hypertension and diabetes among the population  
largely depends on the capacity of health system to 
provide diagnostic services to the general population 
(28, 29). Condition of raised blood pressure and 
elevated blood glucose is mainly asymptomatic and in 
order to make population aware of their health 
condition, there is a need to screen all adults at health 
facility and community outreach programs. Detecting 
major NCDs early will help to prevent complications 
like myocardial infarction, stroke, kidney failure, 
amputations and visual impairment that are costly to 
treat (30). 
 
Limitation and strength of the study:  Possible 
limitations of this study include the cross sectional 
nature of the study that cannot be used to establish 
temporal relationship between the exposures and 
outcome variables (raised blood pressure and elevated 
blood glucose). The adequacy of sample size with good 
response rate from the population and the weighted 
analysis of findings make it generalizable to all 
populations of Ethiopia. Furthermore, the study used 
steps approach (behavioural, physical measurements 
and biochemical measurements) which enabled the 
study to be comprehensive. 
 
Conclusion: 
The prevalence of undetected raised blood pressure and 
elevated blood sugar is high in Ethiopia and only very 
small percentage of people had been aware of their 
high blood pressure and elevated blood sugar.  
Therefore, the high prevalence of raised blood pressure 
and elevated blood sugar in general and the majority of 
undetected risk factor status of these population in 
particular is an indication for community based NCD 
risk factor screening programs.  
 
Recommendations  
Policy makers in the health sector need to strengthen 
the health system and design nation-wide population 
based strategy in collaboration with other health 
development partners to establish screening program 
for raised blood pressure and elevated blood sugar. The 
screening program can be implemented at primary 
health care level, especially the health extension 
program and health centre level. There is also a need to 
increase community awareness on the risks of raised 
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